Atomoxetine Hydrochloride

CAS 82248-59-7 16 current records 2 historicalSmall Molecule

Who holds supplier records for Atomoxetine Hydrochloride? 16 organisations hold a current record for Atomoxetine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (12), Taiwan (1), Canada (1), China (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Atomoxetine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/atomoxetine-hydrochloride

Reading the evidence

  • 16 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    12 of the 16 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (16)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Atomoxetine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Atomoxetine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (8)

Certificates of Suitability on the EDQM register for Atomoxetine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 12 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2026-406 - Rev 00
Atomoxetine hydrochloride, Process-II
Nov 2026—
ZYDUS LIFESCIENCES LIMITED VadodaraIN
CEP 2019-236 - Rev 02
Atomoxetine hydrochloride, Form-A
Oct 2026—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2013-271 - Rev 04
Atomoxetine hydrochloride
Sept 2025—
COHANCE LIFESCIENCES LIMITED MumbaiIN
CEP 2019-212 - Rev 03
Atomoxetine hydrochloride, Process 2
Jul 2025—
HETERO LABS LIMITED HyderabadIN
CEP 2020-091 - Rev 02
Atomoxetine hydrochloride, Form-A, Process II
Mar 2025—
SCI PHARMTECH, INC. Taoyuan CityTW
CEP 2017-029 - Rev 04
Atomoxetine hydrochloride
Dec 2024—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
CEP 2017-073 - Rev 02
Atomoxetine hydrochloride
Apr 2024—
MSN ORGANICS PRIVATE LIMITED Bibinagar VillageIN
R1-CEP 2016-025 - Rev 00
Atomoxetine hydrochloride
Sept 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Atomoxetine Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
    China · Inactive DMF 20208 · filed Jan 2007
  • Italy · Inactive DMF 19623 · filed Jul 2006

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Atomoxetine Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1702).

Chemical identity

IUPAC name
(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine;hydrochloride
Canonical SMILES
CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2.Cl
InChIKey
LUCXVPAZUDVVBT-UNTBIKODSA-N
Synonyms
Atomoxetine (as hydrochloride), Atomoxetine hcl, Atomoxetine hydrochloride, LY-139603, NSC-759104, (r)-(-)-tomoxetine hydrochloride, Strattera, Tomoxetine, Tomoxetine hydrochloride, (R)-Tomoxetine hydrochloride, CHEBI:331697, HCl, Atomoxetine

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Norepinephrine Reuptake Inhibitor
Mechanism of action
Norepinephrine Uptake Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Atomoxetine Hydrochloride?

16 organisations hold an active US FDA Type II Drug Master File or a CEP for Atomoxetine Hydrochloride: APITORIA PHARMA PRIVATE LTD (India), COHANCE LIFESCIENCES LTD (India), Hetero Labs Limited (India), Macleods Pharmaceuticals Ltd. (India), MATRIX PHARMACORP PRIVATE LTD (India), MSN Organics Private Limited (India), SCI PHARMTECH INC (Taiwan) and Zydus Lifesciences Limited (India), and 8 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Atomoxetine Hydrochloride Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 19605), COHANCE LIFESCIENCES LTD (DMF 29211), Hetero Labs Limited (DMF 20246), Macleods Pharmaceuticals Ltd. (DMF 30754), MATRIX PHARMACORP PRIVATE LTD (DMF 19861), MSN Organics Private Limited (DMF 29868), SCI PHARMTECH INC (DMF 32363) and Zydus Lifesciences Limited (DMF 20364) and 8 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Atomoxetine Hydrochloride records mean?

2 organisations have only inactive Type II DMFs for Atomoxetine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Atomoxetine Hydrochloride have a European Certificate of Suitability?

Yes. 8 organisations hold a valid CEP for Atomoxetine Hydrochloride on the EDQM register, including APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), ZYDUS LIFESCIENCES LIMITED Vadodara (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), COHANCE LIFESCIENCES LIMITED Mumbai (IN), HETERO LABS LIMITED Hyderabad (IN) and SCI PHARMTECH, INC. Taoyuan City (TW) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Atomoxetine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Atomoxetine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.